慢性肾病-话题@MedSci

#慢性肾病#

11篇内容 | 3153人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2192905, encodeId=20ca2192905eb, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=fc66824e015' target=_blank style='color:#2F92EE;'>#肾功能下降#</a> <a href='/topic/show?id=d088536467a' target=_blank style='color:#2F92EE;'>#慢性肾病患者#</a>, objectTitle=慢性肾病患者3年内肾功能下降风险预测评分, objectType=article, longId=816924, objectId=7c398169248c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867662026_4754896.png, objectUrl=/article/show_article.do?id=7c398169248c, replyNumber=0, likeNumber=67, createdTime=2024-03-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7c398169248c, moduleTitle=慢性肾病患者3年内肾功能下降风险预测评分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c398169248c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2189605, encodeId=bf08218960557, content=<a href='/topic/show?id=de7a8824163' target=_blank style='color:#2F92EE;'>#葡萄糖#</a> <a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=72148400568' target=_blank style='color:#2F92EE;'>#胰高血糖素#</a>, objectTitle=Cell Metab：新研究揭示肾脏中的胰高血糖素在维持肾脏健康中起着关键作用, objectType=article, longId=814496, objectId=b38081449685, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240224/1708739037690_2185383.png, objectUrl=/article/show_article.do?id=b38081449685, replyNumber=0, likeNumber=86, createdTime=2024-02-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181290, encodeId=a82f21812902e, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=7d0c1099e0c1' target=_blank style='color:#2F92EE;'>#术后急性肾损伤#</a>, objectTitle=Anesthesia & Analgesia：慢性肾病的进展与术后急性肾损伤的发生而非严重度相关, objectType=article, longId=805653, objectId=afaa8056539c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/group-of-surgeons-in-operating-room-at-hospital-PBS9LGH.jpg, objectUrl=/article/show_article.do?id=afaa8056539c, replyNumber=0, likeNumber=93, createdTime=2024-01-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=afaa8056539c, moduleTitle=Anesthesia & Analgesia：慢性肾病的进展与术后急性肾损伤的发生而非严重度相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afaa8056539c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2173929, encodeId=b3c021e392933, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> 根治性膀胱切除术（RC）是治疗肌层浸润性膀胱癌（MIBC）的标准方法。然而，RC后围手术期并发症的发生率很高。当前治疗肌层浸润性膀胱癌的指南建议，应考虑患者的预期寿命。据报道，大部分未经治疗的肌层浸润性膀胱癌患者会在 5 年内死于膀胱癌，表明应尽可能提供根治性治疗。微创手术有可能降低围手术期并发症的发生率，同时不影响肿瘤治疗效果。, objectTitle=慢性肾病, objectType=topic, longId=53642, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606874316685_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=70, createdTime=2023-12-09, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, status=1, hasArticle=0, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2173861, encodeId=5e5b21e3861b1, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=835f85e63f9' target=_blank style='color:#2F92EE;'>#膀胱#</a> <a href='/topic/show?id=64af1083e936' target=_blank style='color:#2F92EE;'>#Charlson 综合征指数#</a>, objectTitle=Int J Urol：慢性肾病和 Charlson 综合征指数可预测机器人辅助根治性膀胱切除术后的并发症：一项日本单中心研究, objectType=article, longId=804254, objectId=bf0a8042546d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231209/1702091712263_1935437.jpg, objectUrl=/article/show_article.do?id=bf0a8042546d, replyNumber=0, likeNumber=145, createdTime=2023-12-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bf0a8042546d, moduleTitle=Int J Urol：慢性肾病和 Charlson 综合征指数可预测机器人辅助根治性膀胱切除术后的并发症：一项日本单中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf0a8042546d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2171371, encodeId=581121e13715b, content=好<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> , objectTitle=JAMA Intern Med：年龄因素对慢性肾病诊断率的影响, objectType=article, longId=216636, objectId=f8b1216636ed, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202192/1630579302582_2051781.jpg, objectUrl=/article/show_article.do?id=f8b1216636ed, replyNumber=0, likeNumber=88, createdTime=2023-11-27, rootId=0, userName=zhangxy712, userId=0c811586618, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f8b1216636ed, moduleTitle=JAMA Intern Med：年龄因素对慢性肾病诊断率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8b1216636ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2170743, encodeId=524621e07436e, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=7c2616228bc' target=_blank style='color:#2F92EE;'>#SGLT2抑制剂#</a>, objectTitle=成人慢性肾病迎来新疗法：SGLT2抑制剂「恩格列净」在华获批, objectType=article, longId=801915, objectId=762080191506, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867668820_4754896.png, objectUrl=/article/show_article.do?id=762080191506, replyNumber=0, likeNumber=96, createdTime=2023-11-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=762080191506, moduleTitle=成人慢性肾病迎来新疗法：SGLT2抑制剂「恩格列净」在华获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=762080191506)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1200117, encodeId=76ab120011e15, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a>学习。, objectTitle=慢性肾病, objectType=topic, longId=53642, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606874316685_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=98, createdTime=2022-03-07, rootId=0, userName=moyanju2796, userId=cbcd5675699, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1196248, encodeId=7734119624873, content=<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a>学习呢, objectTitle=慢性肾病, objectType=topic, longId=53642, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606874316685_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=0, createdTime=2022-02-22, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1073677, encodeId=89fd10e36774a, content=学习了<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a>, objectTitle=晚期肾病骨质疏松症的诊断和治疗, objectType=article, longId=220010, objectId=9b9b2200101e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/t1h.jpg, objectUrl=/article/show_article.do?id=9b9b2200101e, replyNumber=0, likeNumber=142, createdTime=2021-11-24, rootId=0, userName=1228d32am78(暂无昵称), userId=10a92340475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b9b2200101e, moduleTitle=晚期肾病骨质疏松症的诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b9b2200101e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=915209, encodeId=7af49152091c, content=<a href='/topic/show?id=d90393941be' target=_blank style='color:#2F92EE;'>#达格列净#</a>＆<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a>, objectTitle=阿斯利康达格列净治疗慢性肾病适应症获FDA优先审评资格, objectType=article, longId=205578, objectId=ddb72055e8b9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610209670302_2119349.jpg, objectUrl=/article/show_article.do?id=ddb72055e8b9, replyNumber=0, likeNumber=247, createdTime=2021-01-10, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddb72055e8b9, moduleTitle=阿斯利康达格列净治疗慢性肾病适应症获FDA优先审评资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddb72055e8b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=904584, encodeId=13b190458497, content=在患有严重CKD和2型糖尿病的患者中，非利奈酮可减缓CKD的进展并降低心血管疾病的发病率和死亡率。<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a>, objectTitle=NEJM：非奈利酮对2型糖尿病患者慢性肾脏病结果的影响, objectType=article, longId=204083, objectId=42d4204083ef, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020123/1606964853151_5409216.png, objectUrl=/article/show_article.do?id=42d4204083ef, replyNumber=0, likeNumber=197, createdTime=2020-12-03, rootId=0, userName=Psycho.Dr Du, userId=a8fb2299762, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42d4204083ef, moduleTitle=NEJM：非奈利酮对2型糖尿病患者慢性肾脏病结果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42d4204083ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=888258, encodeId=b8168882584c, content=严重的主动脉瓣狭窄患者中度和重度CKD应优先选择AVR<a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a>, objectTitle=JAHA：严重主动脉瓣狭窄与慢性肾脏疾病的关系, objectType=article, longId=201198, objectId=301f2011980d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020925/1600963253314_1739456.jpg, objectUrl=/article/show_article.do?id=301f2011980d, replyNumber=0, likeNumber=219, createdTime=2020-09-25, rootId=0, userName=Psycho.Dr Du, userId=a8fb2299762, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=301f2011980d, moduleTitle=JAHA：严重主动脉瓣狭窄与慢性肾脏疾病的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=301f2011980d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢性肾病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肾病# #肾功能下降# #慢性肾病患者#

慢性肾病患者3年内肾功能下降风险预测评分

2024-03-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#葡萄糖# #慢性肾病# #胰高血糖素#

2024-02-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肾病# #术后急性肾损伤#

Anesthesia & Analgesia：慢性肾病的进展与术后急性肾损伤的发生而非严重度相关

2024-01-13发表于上海

yangchou (审核中...)

前往app查看评论内容

全文收起 #慢性肾病# 根治性膀胱切除术（RC）是治疗肌层浸润性膀胱癌（MIBC）的标准方法。然而，RC后围手术期并发症的发生率很高。当前治疗肌层浸润性膀胱癌的指南建议，应考虑患者的预期寿命。据报道，大部分未经治疗的肌层浸润性膀胱癌患者会在 5 年内死于膀胱癌，表明应尽可能提供根治性治疗。微创手术有可能降低围手术期并发症的发生率，同时不影响肿瘤治疗效果。

2023-12-09发表于浙江省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肾病# #膀胱# #Charlson 综合征指数#

Int J Urol：慢性肾病和 Charlson 综合征指数可预测机器人辅助根治性膀胱切除术后的并发症：一项日本单中心研究

2023-12-09发表于上海

zhangxy712 (审核中...)

前往app查看评论内容

好#慢性肾病#

JAMA Intern Med：年龄因素对慢性肾病诊断率的影响

2023-11-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肾病# #SGLT2抑制剂#

成人慢性肾病迎来新疗法：SGLT2抑制剂「恩格列净」在华获批

2023-11-24发表于上海

moyanju2796 (审核中...)

前往app查看评论内容

#慢性肾病#学习。

2022-03-07

雪莲药师 (审核中...)

前往app查看评论内容

#慢性肾病#学习呢

2022-02-22

1228d32am78(暂无昵称) (审核中...)

前往app查看评论内容

学习了#慢性肾病#

晚期肾病骨质疏松症的诊断和治疗

2021-11-24

zb1235672 (审核中...)

前往app查看评论内容

#达格列净#＆#慢性肾病#

阿斯利康达格列净治疗慢性肾病适应症获FDA优先审评资格

2021-01-10

Psycho.Dr Du (审核中...)

前往app查看评论内容

在患有严重CKD和2型糖尿病的患者中，非利奈酮可减缓CKD的进展并降低心血管疾病的发病率和死亡率。#慢性肾病#

NEJM：非奈利酮对2型糖尿病患者慢性肾脏病结果的影响

2020-12-03

Psycho.Dr Du (审核中...)

前往app查看评论内容

严重的主动脉瓣狭窄患者中度和重度CKD应优先选择AVR#慢性肾病#

JAHA：严重主动脉瓣狭窄与慢性肾脏疾病的关系

2020-09-25

科室
- - 订阅+
  - 更多科室
工具
服务